Report Content
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definition
1.3 Base estimates & calculations
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data Sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Postbiotic Supplements industry 360º synopsis, 2018 – 2032
2.2 Business trends
2.3 Type trends
2.4 Form trends
2.5 Distribution channel trends
2.6 Application trends
2.7 Regional trends
Chapter 3 Postbiotic Supplements Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.2 Industry pitfalls & challenges
3.3 Growth potential analysis
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.5.1 U.S.
3.5.2 Europe
3.6 Pricing analysis, 2022
3.7 Technology landscape
3.7.1 Future market trends
3.8 Porter's analysis
3.9 PESTEL analysis
3.10 Russia-Ukraine War Impact on the industry
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Postbiotic Supplements Market Size and Forecast, By Type 2018 - 2032
5.1 Lipopolysaccharides (LPS)
5.2 Short-chain fatty acids (SCFAs)
5.3 Indole derived from tryptophan
5.4 Muramyl dipeptide (MDP)
5.5 Other
Chapter 6 Postbiotic Supplements Market Size and Forecast, By Form 2018 - 2032
6.1 Liquid
6.2 Capsules and Tablets
6.3 Powder
6.4 Others
Chapter 7 Postbiotic Supplements Market Size and Forecast, By Distribution channel 2018 - 2032
7.1 Supermarkets/hypermarkets
7.2 Drug stores
7.3 Convenience stores
7.4 Online retail
7.5 Other
Chapter 8 Postbiotic Supplements Market Size and Forecast, By Application 2018 - 2032
8.1 Food and beverages
8.2 Nutritional supplements
8.3 Pharmaceuticals
8.4 Other
Chapter 9 Postbiotic Supplements Market Size and Forecast, By Region 2018 - 2032
9.1 Key trends, by region
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Indonesia
9.4.7 Malaysia
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 MEA
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Egypt
Chapter 10 Company Profiles
10.1 Archer Daniels Midland Company
10.2 POSTBIOTICA S.R.L.
10.3 Cargill, Incorporated
10.4 MCLS Europe
10.5 Sami-Sabinsa Group Limited
10.6 woresan GmbH
10.7 Novachem SRL
10.8 Church & Dwight Co., Inc
10.9 ILDONG HOLDINGS CO.,LTD.
10.10 Danish Agro
10.11 Kirin Holdings Company, Limited.
10.12 Lamberti S.p.A
10.13 Adare Pharma Solutions
10.14 Bioflag Group
10.15 Lactobio A/S
